StoneX Group’s Globus Medical GMED Stock Holding History

StoneX Group’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$349K	Buy	+4,480	New	+$355K	0.01%	907

Other funds holding GMED

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Antipodes Partners Royal Exchange, Australia $5.43B AUM 15.86% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Anchor Capital Advisors Boston, Massachusetts $3.21B AUM 13.78% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

StoneX Group's GMED Position: Q3 2026 in Review

StoneX Group opened a new position in Globus Medical (GMED) in Q3 2026: 4,480 shares worth $349K. The stake represents 0.01% of the portfolio and ranks #907 among its holdings.

295 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

StoneX Group held 4,480 shares of Globus Medical worth $349K as of Q3 2026.
Globus Medical was a new StoneX Group position in Q3 2026.
Globus Medical made up 0.01% of StoneX Group's portfolio in Q3 2026, its #907 holding.
295 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.